Literature DB >> 26418172

Genotyping of Toxoplasma gondii Directly from Human and Animal Biological Samples: From Partial Genotypes to a New Genotype.

M M Cunha1, A C A V Carneiro1, J G L Costa1, R W A Vitor1.   

Abstract

Genotyping of Toxoplasma gondii is traditionally performed using DNA obtained from tachyzoites after isolation by bioassay in mice. In this study, genotyping of T. gondii was performed by multiplex nested polymerase chain reaction restriction fragment length polymorphism (Mn-PCR-RFLP) in DNA obtained from the lungs of experimentally infected mice, the hearts of naturally infected free-range chickens, and human blood samples of newborns with congenital toxoplasmosis. The efficiency of Mn-PCR varied according to the marker. We obtained complete genotypes of all of the mice lung samples. In chickens, total or partial genotyping was performed on all of the 15 samples. Two complete genotypes were obtained, including one identified for the first time, and another previously described in different hosts including dogs, cats, and humans. In blood from infants, partial genotypes were obtained in 8 of the 12 samples. Mouse bioassay is the most efficient method to obtain DNA from T. gondii , but direct tissue genotyping enhances the likelihood of obtaining molecular information on T. gondii and is an effective tool as a complement to isolation in mice. In this study, we genotyped Toxoplasma gondii directly from human (blood samples of newborns with congenital toxoplasmosis) and free-range chickens (hearts) by Mn-PCR-RFLP. We present partial and complete genotypes and provide technical and scientific information about T. gondii genotyping methods.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26418172     DOI: 10.1645/15-813

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  7 in total

1.  Toxoplasma genotyping in congenital toxoplasmosis in Upper Egypt: evidence of type I strain.

Authors:  Hanan E M Eldeek; Alzahraa Abdel Raouf Ahmad; Mohamed Ahmed El-Mokhtar; Abdel Rahman M M Abdel Kader; Ahmad M Mandour; Mahmoud Elhady M Mounib
Journal:  Parasitol Res       Date:  2017-07-01       Impact factor: 2.289

2.  Genetic and histopathological characterization of Toxoplasma gondii genotypes isolated from free-range chickens reared in the metropolitan region of Rio de Janeiro state, Brazil.

Authors:  Luciana Casartelli-Alves; Sandro Antonio Pereira; Luiz Cláudio Ferreira; Rodrigo de Macedo Couto; Tânia Maria Pacheco Schubach; Maria Regina Reis Amendoeira; Rodrigo Costa da Silva; Hélio Langoni; Patrícia Riddell Millar; Rodrigo Caldas Menezes
Journal:  Parasitol Res       Date:  2021-01-08       Impact factor: 2.289

3.  Seroprevalence and Genetic Characterization of Toxoplasma gondii among Children with Neurodevelopmental Disorders in Egypt.

Authors:  Sara M Elzeky; Nairmen Nabih; Aida A Abdel-Magied; Dina S Abdelmagid; Aya E Handoussa; Marwa M Hamouda
Journal:  J Trop Med       Date:  2022-05-27

4.  Molecular detection of Toxoplasma gondii in meat for human consumption in Ibague, Colombia

Authors:  Juan David Medina Hernández; Laura Alejandra Osorio Delgado; Daniel Zabala Gonzalez; Ricardo Wagner De Almeida Vitor; Jorge Enrique Gómez; Julio César Carranza; Gustavo Adolfo Vallejo
Journal:  Biomedica       Date:  2022-03-01       Impact factor: 1.173

5.  Functional Analysis of the Rhoptry Kinome during Chronic Toxoplasma gondii Infection.

Authors:  Laura J Knoll
Journal:  mBio       Date:  2016-06-14       Impact factor: 7.867

6.  Prevalence and Genetic Diversity of Toxoplasma gondii in Free-Ranging Chickens from the Caribbean.

Authors:  C M Hamilton; R Robins; R Thomas; C Oura; S Oliveira; I Villena; E A Innes; F Katzer; P J Kelly
Journal:  Acta Parasitol       Date:  2019-05-20       Impact factor: 1.440

7.  Toxoplasma gondii virulence prediction using hierarchical cluster analysis based on coding sequences (CDS) of sag1, gra7 and rop18.

Authors:  Didik T Subekti; Fitrine Ekawasti; Muhammad Ibrahim Desem; Zul Azmi
Journal:  J Vet Sci       Date:  2021-11       Impact factor: 1.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.